Prolactin actions

Journal of Molecular Endocrinology

Volumn 52, Issue 1, 2013, Pages

  Horseman, Nelson D ^a   Gregerson, Karen A ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Female reproduction; Lactation; Parathyroid and bone; Skin

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE RELATED PROTEIN; PROLACTIN; SEROTONIN;

GENE SEQUENCE; HORMONE ACTION; HUMAN; LACTATION; MAMMARY GLAND; MOLECULAR GENETICS; NONHUMAN; ORGAN GROWTH; PATHOPHYSIOLOGY; PERIPARTUM CARDIOMYOPATHY; PRIORITY JOURNAL; PROLACTIN RELEASE; PROLACTIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; SKIN APPENDAGE; TISSUE DIFFERENTIATION;

FEMALE REPRODUCTION; LACTATION; PARATHYROID AND BONE; SKIN;

ANIMALS; BIOLOGICAL EVOLUTION; FEMALE; HUMANS; LACTATION; MAMMARY GLANDS, HUMAN; MICE, TRANSGENIC; PARATHYROID HORMONE-RELATED PROTEIN; PEPTIDE FRAGMENTS; PROLACTIN; RECEPTORS, PROLACTIN; SIGNAL TRANSDUCTION;

EID: 84890891638     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-13-0220     Document Type: Review

References (112)

1. Bao L., Tessier C, Prigent-Tessier A, Li F, Buzzio OL, Callegari EA, Horseman N. D & Gibori G 2007 Decidual prolactin silences the expression of genes detrimental to pregnancy. Endocrinology 148 2326-2334. (doi:10.1210/en.2006-1643)
2. Baxter F. O, Came PJ, Abell K, Kedjouar B, Huth M, Rajewsky K, PasparakisM & Watson CJ 2006 IKKb/2 induces TWEAK and apoptosis in mammary epithelial cells. Development 133 3485-3494. (doi:10.1242/dev.02502)
3. Ben-Jonathan N., Mershon JL, Allen DL & Steinmets RW 1996 Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocrine Reviews 17 639-669.
4. Bern H. A & Nicoll CS 1968 The comparative endocrinology of prolactin. Recent Progress in Hormone Research 24 681-720.
5. Bernichtein S., Kayser C, Dillner K, Moulin S, Kopchick JJ, Martial JA, Norstedt G., Isaksson O, Kelly PA & Goffin V 2003 Development of pure prolactin receptor antagonists. Journal of Biological Chemistry 278 35988-35999. (doi:10.1074/jbc.M305687200)
6. Bernichtein S., Touraine P & Goffin V 2010 New concepts in prolactin biology. Journal of Endocrinology 206 1-11. (doi:10.1677/JOE-10-0069)
7. Berwaer M., Martial JA & Davis JRE 1994 Characterization of an up-stream promoter directing extrapituitary expression of the human prolactin gene. Molecular Endocrinology 8 635. (doi:10.1210/me.8.5.635)
8. Blair J. M, Zheng Y & Dunstan CR 2007 RANK ligand. International Journal of Biochemistry & Cell Biology 39 1077-1081. (doi:10.1016/j.biocel.2006. 11.008)
9. Bogorad R. L, Courtillot C, Mestayer C, Bernichtein S, Harutyunyan L, Jomain J. B, Bachelot A, Kuttenn F, Kelly PA, Goffin V et al. 2008 Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors. PNAS 105 14533-14538. (doi:10.1073/pnas.0800685105)
10. Bole-Feysot C., Goffin V, Edery M, Binart N & Kelly PA 1998 Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocrine Reviews 19 225-268. (doi:10.1210/er.19.3.225)
11. Boutin J., Jolicoeur C, Okamura H, Gagnon J, Edery M, Shirota M, Banville D, Dusanter-Fourt I., Djiane J & Kelly PA 1988 Cloning and expression of the rat prolactin receptor, a member of the growth hormone/ prolactin receptor gene family. Cell 53 69-77. (doi:10.1016/0092-8674(88)90488-6)
12. Brisken C., Kaur S, Chavarria TE, Binart N, Sutherland RL, Weinberg RA, Kelly P. A & Ormandy CJ 1999 Prolactin controls mammary gland development via direct and indirect mechanisms. Developmental Biology 210 96-106. (doi:10.1006/dbio.1999.9271)
13. Brisken C., Ayyannan A, Nguyen C, Heineman A, Reinhardt F, Tan J, Dey SK, Dotto G. P &Weinberg RA 2002 IGF-2 is a mediator of prolactin-induced morphogenesis in the breast. Developmental Cell 3 877-887. (doi:10.1016/S1534-5807(02)00365-9)
14. Brooks C. L 2012 Molecular mechanisms of prolactin and its receptor. Endocrine Reviews 33 504-525. (doi:10.1210/er.2011-1040)
15. Campbell G. S, Argetsinger LS, Ihle JN, Kelly PA, Rillema JA & Carter-Su C 1994 Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants. PNAS 91 5232-5236. (doi:10.1073/pnas.91.12.5232)
16. Cao Y. & Karin M 2003 NF-kB in mammary gland development and breast cancer. Journal of Mammary Gland Biology and Neoplasia 8 215-223. (doi:10.1023/A:1025905008934)
17. Cao Y., Bonizzi G, Seagroves TN, Greten FR, Johnson R, Schmidt EV & Karin M. 2001 IKKa provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell 107 763-775. (doi:10.1016/S0092-8674(01)00599-2)
18. Chen W. Y, Wight DC, Wagner TE & Kopchick JJ 1990 Expression of a mutated bovine growth hormone gene suppresses growth of transgenic mice. PNAS 87 5061-5065. (doi:10.1073/pnas.87.13.5061)
19. Chen W. Y, White ME, Wagner TE & Kopchick JJ 1991 Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice. Endocrinology 129 1402-1408. (doi:10.1210/endo-129-3-1402)
20. Chen T. J, Kuo CB, Tsai KF, Liu JW, Chen DY & Walker AM 1998 Development of recombinant human prolactin receptor antagonists by molecular mimicry of the phosphorylated hormone. Endocrinology 139 609-616. (doi:10.1210/en.139.2.609)
21. Chen W. Y, Ramamoorthy P, Chen N-, Sticca R &Wagner TE 1999 A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis. Clinical Cancer Research 5 3583-3593.
22. Chen C., Stairs DB, Boxer RB, Belka GK, Horseman ND, Alvarez JV & Chodosh L. A 2012 Autocrine prolactin induced by the Pten-Akt pathway is required for lactation initiation and provides a direct link between the akt and Stat5 pathways. Genes and Development 26 2154-2168. (doi:10.1101/gad.197343.112)
23. Choi Y. S, Chakrabarti R, Escamilla-Hernandez R & Sinha S 2009 Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. Developmental Biology 329 227-241. (doi:10.1016/j.ydbio.2009.02.032)
24. Christensen H. R, Murawsky MK, Horseman ND, Willson TA&Gregerson KA 2013 Completely humanizing prolactin rescues infertility in prolactin knockout mice and leads to human prolactin expression in extrapituitary mouse tissues. Endocrinology [in press]. (doi:10.1210/en.2013-1476)
25. Clapp C. 1987 Analysis of the proteolytic cleavage of prolactin by the mammary gland and liver of the rat: characterization of the cleaved and 16k forms. Endocrinology 121 2055-2064. (doi:10.1210/endo-121-6-2055)
26. Clapp C. & Weiner RI 1992 A specific, high affinity, saturable binding site for the 16-kilodalton fragment of prolactin on capillary endothelial cells. Endocrinology 130 1380-1386. (doi:10.1210/en.130.3.1380)
27. Clapp C., Martial JA, Guzman RC, Rentier-Delrue F & Weiner RI 1993 The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133 1292-1299. (doi:10.1210/ en.133.3.1292)
28. Clapp C., Aranda J, González C, Jeziorski MC & de la Escalera GM 2006 Vasoinhibins: endogenous regulators of angiogenesis and vascular function. Trends in Endocrinology and Metabolism 17 301-307. (doi:10.1016/j.tem.2006.08.002)
29. Courtillot C., Chakhtoura Z, Bogorad R, Genestie C, Bernichtein S, Badachi Y., Janaud G, Akakpo JP, Bachelot A, Kuttenn F et al. 2010 Characterization of two constitutively active prolactin receptor variants in a cohort of 95 women with multiple breast fibroadenomas. Journal of Clinical Endocrinology and Metabolism 95 271-279. (doi:10.1210/jc.2009-1494)
30. Craven A. J, Ormandy CJ, Robertson FG, Wilkins RJ, Kelly PA, Nixon AJ, Pearson A. J & Craven T 2001 Prolactin signaling influences the timing mechanism of the hair follicle: analysis of hair growth cycles in prolactin receptor knockout mice. Endocrinology 142 2533-2539. (doi:10.1210/en.142.6.2533)
31. Craven A. J, Nixon AJ, Ashby MG, Ormandy CJ, Blazek K, Wilkins RJ & Pearson A. J 2006 Prolactin delays hair regrowth in mice. Journal of Endocrinology 191 415-425. (doi:10.1677/joe.1.06685)
32. Dalzell J. R, Jackson CE & Gardner RS 2011 An update on peripartum cardiomyopathy. Expert Review of Cardiovascular Therapy 9 1155-1160. (doi:10.1586/erc.11.121)
33. Darnell J. E Jr 1997 STATs and gene regulation. Science 277 1630-1635. (doi:10.1126/science.277.5332.1630)
34. Edery M., Jolicoeur C, Levi-Meyrueis C, Dusanter-Fourt I, Pétridou B, Boutin J., Lesueur L, Kelly PA & Djiane J 1989 Identification and sequence analysis of a second form of prolactin receptor by molecular cloning of complementary DNA from rabbit mammary gland. PNAS 86 2112-2116. (doi:10.1073/pnas.86.6.2112)
35. Edery M., Binart N, Bouchard B, Goffin V & Kelly PA 2001 Prolactin receptors. In Prolactin, pp 341-354. Ed. ND Horseman. Boston: Kluwer Academic Publishers.
36. Emera D., Casola C, Lynch VJ, Wildman DE, Agnew D & Wagner GP 2012 Convergent evolution of endometrial prolactin expression in primates, mice, and elephants through the independent recruitment of transposable elements. Molecular Biology and Evolution 29 239-247. (doi:10.1093/molbev/msr189)
37. Fata J. E, Kong YY, Li J, Sasaki T, Irie-Sasaki J, Moorehead RA, Elliott R, Scully S, Voura E. B, Lacey DL et al. 2000 The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 103 41-50. (doi:10.1016/S0092-8674(00)00103-3)
38. Fernandez-Valdivia R., Mukherjee A, Ying Y, Li J, Paquet M, DeMayo FJ & Lydon J. P 2009 The RANKL signaling axis is sufficient to elicit ductal sidebranching and alveologenesis in themammary gland of the virginmouse. Developmental Biology 328 127-139. (doi:10.1016/j.ydbio.2009.01.019)
39. Ferrara N., Clapp C & Weiner R 1991 The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. Endocrinology 129 896-900. (doi:10.1210/ endo-129-2-896)
40. Foitzik K., Langan EA & Paus R 2009 Prolactin and the skin: a dermatological perspective on an ancient pleiotropic peptide hormone. Journal of Investigative Dermatology 129 1071-1087. (doi:10.1038/jid.2008.348)
41. Garzia E., Clauser R, Persani L, Borgato S, Bulfamante G, Avagliano L, Quadrelli F. & Marconi AM 2013 Prolactin and proinflammatory cytokine expression at the fetomaternal interface in first trimester miscarriage. Fertility and Sterility 100 108-15e1-2. (doi:10.1016/ j.fertnstert.2013.02.053)
42. Gellerson B., Kempf R, Telgmann R & DiMattia GE 1994 Nonpituitary human prolactin gene transcription is independent of pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Molecular Endocrinology 8 356-373. (doi:10.1210/me.8.3.356)
43. Goffin V., Struman I, Mainfroid V, Kinet S & Martial JA 1994 Evidence for a second receptor binding site on human prolactin. Journal of Biological Chemistry 269 32598-32606.
44. Goffin V., Kinet S, Ferrag F, Binart N, Martial JA & Kelly PA 1996 Antagonistic properties of human prolactin analogs that show paradoxical agonistic activity in the Nb2 bioassay. Journal of Biological Chemistry 271 16573-16579. (doi:10.1074/jbc.271.24.14353)
45. Goffin V., Bernichtein S, Kayser C & Kelly PA 2003 Development of new prolactin analogs acting as pure prolactin receptor antagonists. Pituitary 6 89-95. (doi:10.1023/B:PITU.0000004799.41035.9f)
46. Goffin V., Bernichtein S, Touraine P & Kelly PA 2005 Development and potential clinical uses of human prolactin receptor antagonists. Endocrine Reviews 26 400-422. (doi:10.1210/er.2004-0016)
47. Goffin V., Hoang DT, Bogorad RL & Nevalainen MT 2011 Prolactin regulation of the prostate gland: a female player in a male game. Nature Reviews. Urology 8 597-607. (doi:10.1038/nrurol.2011.143)
48. Grimm S. L, Seagroves TN, Kabotyanski EB, Hovey RC, Vonderhaar BK, Lydon J. P, Miyoshi K, Hennighausen L, Ormandy CJ, Lee AV et al. 2002 Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development. Molecular Endocrinology 16 2675-2691. (doi:10.1210/me.2002-0239)
49. Harris J., Stanford PM, Sutherland K, Oakes SR, Naylor MJ, Robertson FG, Blazek K. D, Kazlauskas M, Hilton HN, Wittlin S et al. 2006 Socs2 and elf5 mediate prolactin-induced mammary gland development. Molecular Endocrinology 20 1177-1187. (doi:10.1210/me.2005-0473)
50. Hennighausen L., Robinson GW, Wagner KU & Liu W 1997 Prolactin signaling in mammary gland development. Journal of Biological Chemistry 272 7567-7569. (doi:10.1074/jbc.272.12.7567)
51. Hernandez L. L, Gregerson KA & Horseman ND 2012 Mammary gland serotonin regulates parathyroid hormone-related protein and other bone-related signals. American Journal of Physiology. Endocrinology and Metabolism 302 E1009-E1015. (doi:10.1152/ajpendo.00666.2011)
52. Hilfiker-Kleiner D., Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O., Quint A, Landmesser U, Doerries C et al. 2007 A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128 589-600. (doi:10.1016/j.cell.2006.12.036)
53. Hilfiker-Kleiner D., Struman I, Hoch M, Podewski E & Sliwa K 2012 16-KDa prolactin and bromocriptine in postpartum cardiomyopathy. Current Heart Failure Reports 9 174-182. (doi:10.1007/s11897-012-0095-7)
54. Horseman N. D & Hernandez LL 2013 New concepts of breast cell communication to bone. Trends in Endocrinology and Metabolism [in press]. (doi:10.1016/j.tem.2013.08.004)
55. Horseman N. D & Yu-Lee LY 1994 Transcriptional regulation by the helix bundle peptide hormones: growth hormone, prolactin, and hematopoietic cytokines. Endocrine Reviews 15 627-649.
56. Horseman N. D, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle S. J, Smith F, Markoff E & Dorshkind K 1997 Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO Journal 16 6926-6935. (doi:10.1093/emboj/16.23.6926)
57. Hovey R. C, Harris J, Hadsell DL, Lee AV, Ormandy CJ & Vonderhaar BK 2003 Local insulin-like growth factor-II mediates prolactin-induced mammary gland development. Molecular Endocrinology 17 460-471. (doi:10.1210/me.2002-0214)
58. Ismail P. M, Amato P, Soyal SM, DeMayo FJ, Conneely OM, O'Malley BW & Lydon J. P 2003 Progesterone involvement in breast development and tumorigenesis-as revealed by progesterone receptor "knockout" and "knockin" mouse models. Steroids 68 779-787. (doi:10.1016/S0039-128X(03)00133-8)
59. Kuo C. B, Coss D & Walker AM 1998 Prolactin receptor antagonists. Endocrine 9 121-131. (doi:10.1385/ENDO:9:2:121)
60. LeBaron MJ, Ahonen TJ, Nevalainen MT & Rui H 2007 In vivo responsebased identification of direct hormone target cell populations using high-density tissue arrays. Endocrinology 148 989-1008. (doi:10.1210/ en.2006-1219)
61. Lee H. J & Ormandy CJ 2012 Elf5, hormones and cell fate. Trends in Endocrinology and Metabolism 23 292-298. (doi:10.1016/j.tem. 2012.02.006)
62. Lee H., Struman I, Clapp C, Martial J & Weiner RI 1998 Inhibition of urokinase activity by the antiangiogenic factor 16K prolactin: activation of plasminogen activator inhibitor 1 expression. Endocrinology 139 3696-3703. (doi:10.1210/en.139.9.3696)
63. Lee H. J, Hinshelwood RA, Bouras T, Gallego-Ortega D, Valdes-Mora F, Blazek K., Visvader JE, Clark SJ & Ormandy CJ 2011 Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. Stem Cells 29 1611-1619. (doi:10.1002/stem.706)
64. Lee H. J, Gallego-Ortega D, Ledger A, Schramek D, Joshi P, Szwarc MM, Cho C., Lydon JP, Khokha R, Penninger JM et al. 2013 Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells. Development 140 1397-1401. (doi:10.1242/dev.088948)
65. Liu X., Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A & Hennighausen L. 1997 Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes and Development 11 179-186. (doi:10.1101/gad.11.2.179)
66. Liu X., Gallego MI, Smith GH, Robinson GW & Hennighausen L 1998 Functional release of Stat5a-null mammary tissue through the activation of compensating signals including Stat5b. Cell Growth & Differentiation 9 795-803.
67. Liu Y., Gong W, Breinholt J, Norskov-Lauritsen L, Zhang J, Ma Q, Chen J, Panina S., Guo W, Li T et al. 2011 Discovery of the improved antagonistic prolactin variants by library screening. Protein Engineering, Design & Selection 24 855-860. (doi:10.1093/protein/gzr047)
68. Lorenson M. Y & Walker AM 2001 Structure-function relationships in prolactin. In Prolactin, pp 189-218. Ed. ND Horseman. Boston: Kluwer Academic Publishers.
69. Lubahn D. B, Moyer JS, Golding TS, Couse JF, Korach KS & Smithies O 1993 Alteration of reproductive function but not prenatal sexuial development after insertional disruption of the mouse estrogen receptor gene. PNAS 90 11162-11166. (doi:10.1073/pnas.90.23.11162)
70. Lydon J. P, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA Jr, Shyamala G., Conneely OM & O'Malley BW 1995 Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes and Development 9 2266-2278. (doi:10.1101/gad.9.18.2266)
71. Matsuda M., Imaoka T, Vomachka AJ, Gudelsky GA, Hou Z, Mistry M, Bailey J. P, Nieport KM, Walther DJ, Bader M et al. 2004 Serotonin regulates mammary gland development via an autocrine-paracrine loop. Developmental Cell 6 193-203. (doi:10.1016/ S1534-5807(04)00022-X)
72. Mittra I. 1980a A novel "cleaved prolactin" in the rat pituitary: Part I. biosynthesis, characterization and regulatory control. Biochemical and Biophysical Research Communications 95 1750-1759. (doi:10.1016/ S0006-291X(80)80101-X)
73. Mittra I. 1980b A novel "cleaved prolactin" in the rat pituitary: Part 2 in vivo mammary mitogenic activity of its n-terminal 16k moiety. Biochemical and Biophysical Research Communications 95 1760-1767. (doi:10.1016/ S0006-291X(80)80102-1)
74. Mulac-Jericevic B., Lydon JP, DeMayo FJ & Conneely OM 2003 Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. PNAS 100 9744-9749. (doi:10.1073/pnas. 1732707100)
75. Muller A. F, Kopchick JJ, Flyvbjerg A & Van Der Lely AJ 2004 Growth hormone receptor antagonists. Journal of Clinical Endocrinology and Metabolism 89 1503-1511. (doi:10.1210/jc.2002-022049)
76. Naylor M. J, Lockefeer JA, Horseman ND & Ormandy CJ 2003 Prolactin regulates mammary epithelial cell proliferation via autocrine/paracrine mechanism. Endocrine 20 111-114. (doi:10.1385/ENDO:20:1-2:111)
77. Nevalainen M. T, Valve EM, Ingleton PM, Nurmi M, Martikainen PM & Harkonen P. L 1997 Prolactin and prolactin receptors are expressed and functioning in human prostate. Journal of Clinical Investigation 99 618-627. (doi:10.1172/JCI119204)
78. Nicoll C. S 1980 Prolactin: ontogeny and evolution of prolactin's functions. Federation Proceedings 39 2561-2566.
79. Oakes S. R, Hilton HN & Ormandy CJ 2006 The alveolar switch: coordinating the proliferative cues and cell fate decisions that drive the formation of lobuloalveoli from ductal epithelium. Breast Cancer Research 8 207. (doi:10.1186/bcr1411)
80. Oakes S. R, Naylor MJ, Asselin-Labat ML, Blazek KD, Gardiner-Garden M, Hilton H. N, Kazlauskas M, Pritchard MA, Chodosh LA, Pfeffer PL et al. 2008 The ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes and Development 22 581-586. (doi:10.1101/gad.1614608)
81. Oftedal O. T 2002a The origin of lactation as a water source for parchmentshelled eggs. Journal of Mammary Gland Biology and Neoplasia 7 253-266. (doi:10.1023/A:1022848632125)
82. Oftedal O. T 2002b The mammary gland and its origin during synapsid evolution. Journal of Mammary Gland Biology and Neoplasia 7 225-252. (doi:10.1023/A:1022896515287)
83. Oftedal O. T 2012 The evolution of milk secretion and its ancient origins. Animal 6 355-368. (doi:10.1017/S1751731111001935)
84. Ormandy C. J, Camus A, Barra J, Damotte D, Lucas B, Buteau H, Edery M, Brousse N., Babinet C, Binart N et al. 1997 Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes and Development 11 167-178. (doi:10.1101/gad.11.2.167)
85. Pearson G., Robinson F, Beers Gibson T, Xu B, Karandikar M, Berman K & Cobb M. H 2001 Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocrine Reviews 22 153-183. (doi:10.1210/er.22.2.153)
86. Piwnica D., Touraine P, Struman I, Tabruyn S, Bolbach G, Clapp C, Martial J. A, Kelly PA & Goffin V 2004 Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance. Molecular Endocrinology 18 2522-2542. (doi:10.1210/me.2004-0200)
87. Radhakrishnan A., Raju R, Tuladhar N, Subbannayya T, Thomas JK, Goel R, Telikicherla D., Palapetta SM, Rahiman BA, Venkatesh DD et al. 2012 A pathway map of prolactin signaling. Journal of Cell Communication and Signaling 6 169-173. (doi:10.1007/s12079-012-0168-0)
88. Rawlings J. S, Rosler KM & Harrison DA 2004 The JAK/STAT signaling pathway. Journal of Cell Science 117 1281-1283. (doi:10.1242/jcs.00963)
89. Riddle O., Bates RW & Dykshorn SW 1933 The preparation, identification and assay of prolactin-a hormone of the anterior pituitary. American Journal of Physiology 105 191-216.
90. Risk M. & Gibori G 2001 Mechanisms of luteal cell regulation by prolactin. In Prolactin, pp 265-296. Ed. ND Horseman. Boston: Kluwer Academic Publishers.
91. Rouet V., Bogorad RL, Kayser C, Kessal K, Genestie C, Bardier A, Grattan DR, Kelder B., Kopchick JJ, Kelly PA et al. 2010 Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors. PNAS 107 15199-15204. (doi:10.1073/pnas.0911651107)
92. Schramek D., Leibbrandt A, Sigl V, Kenner L, Pospisilik JA, Lee HJ, Hanada R, Joshi P. A, Aliprantis A, Glimcher L et al. 2010 Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 468 98-102. (doi:10.1038/nature09387)
93. Semprini S., Friedrichsen S, Harper CV, McNeilly JR, Adamson AD, Spiller D. G, Kotelevtseva N, Brooker G, Brownstein DG, McNeilly AS et al. 2009 Real-time visualization of human prolactin alternate promoter usage in vivo using a double-transgenic rat model. Molecular Endocrinology 23 529-538. (doi:10.1210/me.2008-0399)
94. Sidis Y. & Horseman ND 1994 Prolactin induces rapid p95/p70 tyrosine phosphorylation, and protein binding to GAS-like sites in the anx Icp35 and c-fos genes. Endocrinology 134 1979-1985. (doi:10.1210/en.134.4. 1979)
95. Srivastava S., Matsuda M, Hou Z, Bailey JP, Kitazawa R, Herbst MP & Horseman N. D 2003 Receptor activator of NF-kB ligand induction via Jak2 and Stat5a in mammary epithelial cells. Journal of Biological Chemistry 278 46171-46178. (doi:10.1074/jbc.M308545200)
96. Standke G. JR, Meier VS & Groner B 1994 Mammary gland factor activated by prolactin in mammary epithelial cells and acute-phase response factor activated by interleukin-6 in liver cells share DNA binding and transactivation potential. Molecular Endocrinology 8 469-477. (doi:10.1210/me.8.4.469)
97. Steger R. W, Chandrashekar V, Zhao W, Bartke A & Horseman ND 1998 Neuroendocrine and reproductive functions in male mice with targeted disruption of the prolactin gene. Endocrinology 139 3691-3695. (doi:10.1210/en.139.9.3691)
98. Stricker P. & Grueter F 1928 Action du lobe antérior de l'hypophyse sur la montée laiteuse. Comptes Rendus de la Societie de Biologie 99 1978-1980.
99. Tarulli G. A, De Silva D, Ho V, Kunasegaran K, Ghosh K, Tan BC, Bulavin DV & Pietersen AM 2013 Hormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epithelium. Breast Cancer Research 15 R10. (doi:10.1186/bcr3381)
100. Vomachka A. J, Pratt SL, Lockefeer JA & Horseman ND 2000 Prolactin genedisruption arrests mammary gland development and retards T-antigeninduced tumor growth. Oncogene 19 1077-1084. (doi:10.1038/sj.onc. 1203348)
101. Wada T., Nakashima T, Hiroshi N & Penninger JM 2006 RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends in Molecular Medicine 12 17-25. (doi:10.1016/j.molmed.2005.11.007)
102. Wagner K. U, Krempler A, Triplett AA, Qi Y, George NM, Zhu J & Rui H 2004 Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice. Molecular and Cellular Biology 24 5510-5520. (doi:10.1128/MCB.24.12.5510-5520.2004)
103. Wakao H., Gouilleux F & Groner B 1995 Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO Journal 14 854-855.
104. Walker A. M 2007 S179D prolactin: antagonistic agony! Molecular and Cellular Endocrinology 276 1-9. (doi:10.1016/j.mce.2007.06.001)
105. Walker V. R & Korach KS 2004 Estrogen receptor knockout mice as a model for endocrine research. ILAR Journal/National Research Council, Institute of Laboratory Animal Resources 45 455-461. (doi:10.1093/ilar.45.4.455)
106. Watson C. J & Burdon TG 1996 Prolactin signal transduction mechanisms in the mammary gland: the role of the Jak/Stat pathway. Reviews of Reproduction 1 1-5. (doi:10.1530/ror.0.0010001)
107. Wells J. A & de Vos AM 1996 Hematopoietic receptor complexes. Annual Review of Biochemistry 65 609-634. (doi:10.1146/annurev.bi.65.070196. 003141)
108. Wysolmerski J. J 2012 Parathyroid hormone-related protein: an update. Journal of Clinical Endocrinology and Metabolism 97 2947-2956. (doi:10.1210/jc.2012-2142)
109. Yamac H., Bultmann I, Sliwa K & Hilfiker-Kleiner D 2010 Prolactin: a new therapeutic target in peripartum cardiomyopathy. Heart 96 1352-1357. (doi:10.1136/hrt.2009.179218)
110. Yamaji D., Na R, Feuermann Y, Pechhold S, Chen W, Robinson GW & Hennighausen L. 2009 Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. Genes and Development 23 2382-2387. (doi:10.1101/gad. 1840109)
111. Zhou J., Chehab R, Tkalcevic J, Naylor MJ, Harris J, Wilson TJ, Tsao S, Tellis I, Zavarsek S., Xu D et al. 2005 Elf5 is essential for early embryogenesis and mammary gland development during pregnancy and lactation. EMBO Journal 24 635-644. (doi:10.1038/sj.emboj.7600538)
112. Zhu Y. H & Bulavin DV 2012 Wip1-dependent signaling pathways in health and diseases. Progress in Molecular Biology and Translational Science 106 307-325.